In a rapidly evolving healthcare landscape, the convergence of artificial intelligence (AI) and value-based care represents one of the most significant shifts in the history of American medicine. Recently, Charles N. Kahn III, a senior visiting fellow at KFF, hosted Dr. Patrick Conway, CEO of Optum, on the podcast The Business of Health. Their discussion offered a rare, high-level glimpse into how the nation’s largest integrated health services company is leveraging massive capital investment—over $1.5 billion—to dismantle traditional administrative barriers and prioritize patient outcomes.
The Architect of Value-Based Care
To understand the current transformation at Optum, one must first look at the professional trajectory of Dr. Patrick Conway. Few individuals in the American healthcare sector have occupied as many influential vantage points. Conway’s career includes high-level roles as a regulator at the Centers for Medicare and Medicaid Services (CMS), where he helped design value-based payment models; a payer role as the CEO of Blue Cross and Blue Shield of North Carolina; and his current leadership at the helm of Optum.
This breadth of experience allows Conway to view the healthcare system not as a series of fragmented silos, but as an interconnected ecosystem. During the podcast, he noted that when he first began his work at the CMS Innovation Center, value-based care models—where payments are tied to quality and total cost of care rather than the volume of services—were in their infancy. Today, he argues that the industry is at a tipping point where integration and AI will finally allow these models to achieve dominance.
Chronology of an Industry Pivot
The transition toward value-based care has occurred in distinct phases over the last decade.
- 2011–2016 (The Foundation): During his tenure at CMS, Conway oversaw the launch of the Accountable Care Organization (ACO) program. Participation grew from near-zero to over 30% by the end of 2016, setting a precedent for public-sector commitment to value-based payment.
- 2017–2020 (The Private Sector Scaling): Upon moving to Blue Cross and Blue Shield of North Carolina, Conway led an aggressive pivot, shifting over 70% of the insurer’s payments into value-based models within just 18 months.
- 2021–Present (The AI-Powered Integration): Now at Optum, the focus has shifted to scaling these models using technology. The organization currently manages an integrated care platform serving approximately 20 million patients across 100 different payers.
Supporting Data: AI at Scale
UnitedHealth Group’s massive investment in AI is not merely experimental; it is being operationalized across three primary domains: administrative efficiency, clinical decision support, and patient-provider workflow optimization.
Administrative Transformation
The administrative burden in healthcare is a primary driver of physician burnout. Optum is tackling this through:
- Prior Authorization Reform: By standardizing electronic tools and utilizing AI, Optum has reduced the prior authorization process for some pharmacy benefits from days or weeks to under 30 seconds.
- Claims Adjudication: Through the "Optum Real" platform, the company is moving toward real-time settlement of claims, allowing for 99% approval rates at the point of care, providing patients with transparency regarding their financial responsibilities before they leave the exam room.
- Call Center Reduction: With approximately 300 million calls handled annually by UnitedHealth Group, the company aims to leverage AI to reduce this volume by 50% over the next 18 months, automating responses and streamlining information retrieval.
Clinical and Diagnostic Support
Perhaps the most transformative aspect of the technology lies in its ability to assist in complex diagnostics. Conway recalled an early-career experience where he spent hours manually reviewing a 1,000-page medical chart to diagnose a child with a rare metabolic disorder. Today, AI can process that same chart in seconds, queuing relevant clinical findings for the physician.
Furthermore, the use of "ambient listening" technology—which automatically transcribes and codes patient-physician interactions—has already saved over 2 million minutes of clinician documentation time within the Optum system. This shift allows doctors to return to their primary mission: patient care.
Official Responses and Ethical Guardrails
A central theme of the discussion was the potential for conflict when a single entity bears financial risk while simultaneously building the AI that dictates coverage decisions. Kahn challenged Conway on how the company ensures that patients, not profit margins, remain the priority.
Conway emphasized that Optum maintains an internal AI Review Board dedicated to ensuring that technology serves patient safety first. A core principle of their deployment is that "a human must always have the final say." For any AI-driven decision that involves a "redirection of care" or the denial of a requested therapy, a qualified clinician—such as a doctor or nurse practitioner—must review and sign off on the decision.
Regarding public transparency, Conway pointed to the company’s recent commitment to 100% transparency in its pharmacy benefit management (PBM) operations, including a full pass-through of rebates and cost-based reimbursement for all drugs. He argued that similar levels of transparency regarding AI algorithms are essential to maintaining public trust.
Implications for the Future of Healthcare
The broader implications of this technological surge are profound, particularly regarding the survival of independent providers and rural health systems.
The Rural Healthcare Crisis
Conway acknowledged the "rural desert" phenomenon, where hospital closures have forced patients to travel hours for basic care. He believes that the solution lies in a hybrid approach:
- Public-Private Collaboration: Utilizing models like those tested in Pennsylvania and Vermont, where rural hospitals receive support to transition from large inpatient footprints to more sustainable emergency and community-based models.
- Scalability: While some critics view consolidation as a threat to independent practice, Conway argues that small, rural practices cannot feasibly participate in complex value-based care models without the technological and administrative support of a larger platform.
The Evolution of Metrics
A significant breakthrough expected from the AI era is the shift from "structural or process" metrics to "outcome-oriented" measures. Historically, policymakers relied on claims data because it was the only data that was easily collectible. AI now enables the collection and analysis of real-time clinical outcomes, allowing for a more nuanced and accurate assessment of whether a patient’s health is actually improving.
Closing Reflections: The Human Element
Despite the focus on artificial intelligence, both Kahn and Conway agreed that technology is merely an enabler. The ultimate goal remains the human connection. Conway closed the conversation with a poignant story from Lafayette, Louisiana, where a hospice nurse—supported by Optum’s care platform—cared for a patient who was also her neighbor.
"You give physicians the ability to practice and deliver amazing clinical care, that’s why they went into medicine," Conway said. "If you do the opposite and create barriers or paperwork, you end up burning people out."
As the healthcare industry continues to integrate AI, the challenge will be to ensure that the technology serves to amplify the caring nature of the profession, rather than replacing the essential human touch that patients require at their most vulnerable moments. The transition to a fully realized value-based system, powered by AI and anchored by clinical expertise, remains the primary objective for the next generation of American healthcare.
About the Author
